Influence
January 9, 2020

Regenstrief VP breaking ground in artificial intelligence education in conjunction with National Academy of Medicine, other partners

Eneida Mendonca, Regenstrief Institute, VP for Research DevelopmentRegenstrief Vice President for Research Development Eneida Mendonca, M.D., PhD, is playing a crucial role in the creation of a groundbreaking publication on artificial intelligence in healthcare from the National Academy of Medicine. The document is viewed as a reference for all stakeholders involved in AI and healthcare. Dr. Mendonca is a co-lead on the chapter considering the tradeoffs and unintended consequences of AI and a co-author on the chapter exploring the deployment of AI in clinical settings. She stresses the importance of carefully monitoring the uses and outcomes after AI implementation to correct any negative consequences and the adoption of general IT governance structures to manage AI.  The publication is called “Artificial Intelligence in Health Care: The Hope, The Hype, The Promise, and The Peril.”

Related News

illustration of the combination of interventions used in the D3 pragmatic clinical trial

Zero-cost, AI-driven digital detection identifies Alzheimer’s and related dementias without additional clinician time

Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time

Arthur H. Owora, PhD

Predictive correlates of poor sleep associated with increased risk of severe asthma exacerbations among children with moderate-to-severe asthma

Published in Pediatric Allergy and Immunology. Here is a link to the article. Regenstrief Institute author: Arthur H. Owora,

Atlanta City Skyline

Regenstrief Institute experts will lead presentations, participate in panels at the AMIA 2025

Regenstrief Institute informaticians and other data experts will share their research insights and innovations from November 15-19 during the